Mary Crowley Medical Research Center; Oncology

Dallas, Texas 75246

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Neoplasms, Ovarian Cancer, Prostate Cancer

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. — Completed
• An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol — Completed